A decade of innovation in pharmaceutical R&D: the Chorus model

被引:0
|
作者
Paul K. Owens
Eyas Raddad
Jeffrey W. Miller
John R. Stille
Kenneth G. Olovich
Neil V. Smith
Rosie S. Jones
Joel C. Scherer
机构
[1] The Chorus Group,
[2] Lilly Research Laboratories,undefined
[3] Eli Lilly and Company,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Chorus is a small, operationally independent organization within Eli Lilly and Company that specializes in drug development from candidate selection through to clinical proof of concept. Here, we describe its development philosophy, organizational structure, operational model and results in the decade since it was established, which indicate substantial productivity improvements in both time and cost compared to traditional drug development approaches.
引用
收藏
页码:17 / 28
页数:11
相关论文
共 50 条
  • [1] A decade of innovation in pharmaceutical R&D: the Chorus model
    Owens, Paul K.
    Raddad, Eyas
    Miller, Jeffrey W.
    Stille, John R.
    Olovich, Kenneth G.
    Smith, Neil V.
    Jones, Rosie S.
    Scherer, Joel C.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 17 - 28
  • [2] Formulation of a Success Model in Pharmaceutical R&D: Efficient Innovation Model
    Kim, Hyunju Rachel
    [J]. SAGE OPEN, 2014, 4 (01):
  • [3] Innovation in pharmaceutical R&D: mapping the research landscape
    Angelo Kenneth S. Romasanta
    Peter van der Sijde
    Jacqueline van Muijlwijk-Koezen
    [J]. Scientometrics, 2020, 125 : 1801 - 1832
  • [4] R&D in the pharmaceutical industry and the US investment in innovation
    Wollowitz, S
    Kermani, F
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U251 - U251
  • [5] Innovation in pharmaceutical R&D: mapping the research landscape
    Romasanta, Angelo Kenneth S.
    van der Sijde, Peter
    Van Muijlwijk-Koezen, Jacqueline
    [J]. SCIENTOMETRICS, 2020, 125 (03) : 1801 - 1832
  • [6] Public subsidies for R&D and public sector pharmaceutical innovation
    Kourouklis, Dimitrios
    [J]. APPLIED ECONOMICS, 2021, 53 (32) : 3759 - 3777
  • [7] Racing to define pharmaceutical R&D external innovation models
    Wang, Liangsu
    Plump, Andrew
    Ringel, Michael
    [J]. DRUG DISCOVERY TODAY, 2015, 20 (03) : 361 - 370
  • [8] Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D
    Drews, J
    [J]. DRUG DISCOVERY TODAY, 1998, 3 (11) : 491 - 494
  • [9] Innovation in the pharmaceutical industry: New estimates of R&D costs
    DiMasi, Joseph A.
    Grabowski, Henry G.
    Hansen, Ronald W.
    [J]. JOURNAL OF HEALTH ECONOMICS, 2016, 47 : 20 - 33
  • [10] Innovation and R&D
    Vaughn, C
    [J]. CHEMICAL & ENGINEERING NEWS, 2001, 79 (13) : 227 - 227